UMass Chan Medical School at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
UMass Chan Medical School brings 6 presentations to ASH 2026 in New Orleans. Its research spans myelodysplastic syndromes, CAR T-cell therapy and transplant. Work covers TP53-mutant relapse after transplant, infections after CAR T therapy and risk in transformed follicular lymphoma.
| Organization | ASH 2026 Attendance |
|---|---|
UMass Chan Medical School Worcester, MA | |
Public medical school of the University of Massachusetts in Worcester. | Session Fri Dec 11 3:00pm–6:00pm Scientific Workshop on TP53: A Moving Target Mutations in the p53 gene bring a very poor outlook in myeloid cancers, and this workshop follows them from first mutation to therapy. Session Fri Dec 11 5:55pm–6:00pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sun Dec 13 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at UMass Chan Medical School
Tell us what you sell and we’ll find the people at UMass Chan Medical School most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction